Cibc Private Wealth Group, LLC Axsome Therapeutics, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $51.3 Billion
- Q1 2025
A detailed history of Cibc Private Wealth Group, LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 13,715 shares of AXSM stock, worth $1.44 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,715
Previous 16,214
15.41%
Holding current value
$1.44 Million
Previous $1.37 Million
16.63%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding AXSM
# of Institutions
407Shares Held
36.2MCall Options Held
751KPut Options Held
568K-
Vanguard Group Inc Valley Forge, PA3.88MShares$407 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$346 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.92MShares$307 Million5.58% of portfolio
-
Bvf Inc San Francisco, CA1.69MShares$177 Million8.66% of portfolio
-
Macquarie Group LTD Australia, C3976KShares$102 Million0.14% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.5B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...